Morning Market Losers

tumbled 41.59 percent to $1.28 following announcement that it is suspending the development of its Mydicar program.

shares dropped 21.79 percent to $3.41 after the company priced its $5 million public offering for common stock and warrants at $3.65 per unit.

shares dipped 16.80 percent to $19.99 after the company reported weaker-than-expected results for its fiscal third quarter on Thursday.

shares declined 9.92 percent to $74.17. SYNNEX reported better-than-expected earnings for its fiscal second quarter, but the company's revenue missed analysts' estimates. The company also issued a weak forecast for the current quarter.

shares fell 8.72 percent to $50.55. The decline in the shares may be attributed to negative comments by David Faber on CNBC. Zoetis closed up more than 11 percent Thursday on a report that its the target of takeover interest by

.

shares slipped 2.66 percent to $52.43. Bernstein downgraded ARM Holdings from Market Perform to Underperform.

shares slipped 2.33 percent to $31.25. Analysts at Jefferies maintain their Buy rating for Intel and lowered the target price from $48 to $45.